Janice Jean Murray - Net Worth and Insider Trading
Janice Jean Murray Net Worth
The estimated net worth of Janice Jean Murray is at least $31,615 dollars as of 2024-11-12. Janice Jean Murray is the Director of Knight Therapeutics Inc and owns about 6,115 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $31,615. Details can be seen in Janice Jean Murray's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Janice Jean Murray has not made any transactions after 2022-04-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Janice Jean Murray
Janice Jean Murray Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Janice Jean Murray owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of Janice Jean Murray’s form 4 insider trades.
Insider Ownership Summary of Janice Jean Murray
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2022-04-13 | Director |
Janice Jean Murray Latest Holdings Summary
Janice Jean Murray currently owns a total of 1 stock. Janice Jean Murray owns 6,115 shares of Knight Therapeutics Inc (TSX:GUD) as of April 13, 2022, with a value of $31,615.
Latest Holdings of Janice Jean Murray
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2022-04-13 | 6,115 | 5.17 | 31,615 |
Holding Weightings of Janice Jean Murray
Janice Jean Murray Form 4 Trading Tracker
According to the SEC Form 4 filings, Janice Jean Murray has made a total of 2 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Knight Therapeutics Inc is the acquisition of 1,900 shares on April 13, 2022, which cost Janice Jean Murray around $10,070.
Insider Trading History of Janice Jean Murray
- 1
Janice Jean Murray Trading Performance
GuruFocus tracks the stock performance after each of Janice Jean Murray's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Janice Jean Murray is 3.29%. GuruFocus also compares Janice Jean Murray's trading performance to market benchmark return within the same time period. The performance of stocks bought by Janice Jean Murray within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Janice Jean Murray's insider trading performs compared to the benchmark.
Performance of Janice Jean Murray
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.59 | | | | | |
| Relative Return to S&P 500(%) | 5.71 | | | | | |
Janice Jean Murray Ownership Network
Ownership Network List of Janice Jean Murray
Ownership Network Relation of Janice Jean Murray
Janice Jean Murray Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Janice Jean Murray is the Director of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Director & Senior Officer Samira Sakhia , Senior Officer Amal Khouri , and Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Janice Jean Murray made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 674,800 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 20,100 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 20,000 shares, with a net sale of 100 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 949,000 shares were bought by its insiders, resulting in a net purchase of 634,800 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Janice Jean Murray Mailing Address
Above is the net worth, insider trading, and ownership report for Janice Jean Murray. Currently GuruFocus does not have mailing address information for Janice Jean Murray.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
